Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01391234 · ClinicalTrials.gov registry record · NA
Rapid Radiation Therapy for Painful Osseous Metastatic Disease
A NA study, sponsored by University of Virginia.
- Completed
- Registry status
- NA
- Development phase
- 28
- Enrollment target
NCT01391234 is a NA study that has completed, run by University of Virginia. The registered enrollment target is 28 participants.
The verdict
NCT01391234, a NA study, has completed, sponsored by University of Virginia.
- COMPLETED
- Registry status
- NA
- Development phase
- 28 participants
- Enrollment target
Study Summary
The purpose of this research study is to evaluate the safety and effectiveness of an experimental workflow that may result in a faster way to plan and deliver radiation for the treatment of pain caused by metastatic bone tumors (tumors that originally came from another organ and have spread to bones causing pain) or multiple myeloma (a type of cancer that begins in white blood cells that produce antibodies). The current standard of care radiation treatment planning and delivery takes 2 to 3 weeks from start to finish. The investigators have developed an experimental workflow: a radiation treatment planning and delivery workflow called "STAT RT" (STAT means "right away", and RT means radiation therapy). This experimental workflow may shorten the time it takes to plan and treat painful bone metastases to 1 week or less. All steps in this process will be performed within the current standard of care but in a shorter time frame to allow treatment to start sooner. The investigators will evaluate effectiveness by requesting patients to complete pain and quality of life questionnaires before and after treatment. The investigators will also be collecting additional information from their treatments that will help us make future workflows even more efficient.
Interventions
- RADIATION STAT RT planning and delivery workflow
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 28 participants |
| Start Date | 2011-06 |
| Est. Completion | 2015-05 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01391234
The ClinicalTrials.gov registry entry for NCT01391234 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 28 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Virginia, which has 449 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which STAT RT planning and delivery workflow is the first listed.
NCT01391234 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01391234 about?
NCT01391234 is a clinical study titled "Rapid Radiation Therapy for Painful Osseous Metastatic Disease". The purpose of this research study is to evaluate the safety and effectiveness of an experimental workflow that may result in a faster way to plan and deliver radiation for the treatment of pain caused by metastatic bone tumors (tumors that originally came from another organ and have spread to bones...
What is the current status of trial NCT01391234?
This trial is currently completed. It is a NA study. The enrollment target is 28 participants. The study started on 2011-06. Estimated completion is 2015-05.
What interventions are being tested in trial NCT01391234?
The interventions under investigation include: STAT RT planning and delivery workflow (RADIATION).
Who is sponsoring clinical trial NCT01391234?
This trial is sponsored by University of Virginia, which has 449 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.